Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn's Disease.

Abstract

Crohn's disease recurrence after ileocecal resection is common. Guidelines suggest colonoscopy within 6-12months of surgery to assess for post-operative recurrence, but use of adjunctive monitoring is not protocolized. We aimed to describe the state of monitoring in post-operative Crohn's. We conducted a retrospective study of patients with Crohn's after ileocolic resection with ≥ 1-year follow-up. Patients were stratified into high and low risk based on guidelines. Post-operative biomarker (C-reactive protein, fecal calprotectin), cross-sectional imaging, and colonoscopy use were assessed. Biomarker, radiographic, and endoscopic post-operative recurrence were defined as elevated CRP/calprotectin, active inflammation on imaging, and Rutgeerts ≥ i2b, respectively. Data were stratified by surgery year to assess changes in practice patterns over time. P-values were calculated using Wilcoxon test and Fisher exact test. Of 901 patients, 53% were female and 78% high risk. Median follow-up time was 60m for LR and 50m for high risk. Postoperatively, 18% low and 38% high risk had CRPs, 5% low and 10% high risk had calprotectins, and half of low and high risk had cross-sectional imaging. 29% low and 38% high risk had colonoscopy by 1year. Compared to pre-2015, time to first radiography (584days vs. 398days) and colonoscopy (421days vs. 296days) were significantly shorter for high-risk post-2015 (P < 0.001). Probability of colonoscopy within 1year increased over time (0.48, 2011 vs. 0.92, 2019). Post-operative colonoscopy completion by 1year is low. The use of CRP and imaging are common, whereas calprotectin is infrequently utilized. Practice patterns are shifting toward earlier monitoring.